Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
DONEPEZIL HYDROCHLORIDE
TEVA CANADA LIMITED
N06DA02
DONEPEZIL
10MG
TABLET
DONEPEZIL HYDROCHLORIDE 10MG
ORAL
30/100/500
Prescription
PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS
Active ingredient group (AIG) number: 0131548002; AHFS:
APPROVED
2013-12-24
PRODUCT MONOGRAPH PR TEVA-DONEPEZIL Donepezil Hydrochloride Tablets 5 mg and 10 mg Cholinesterase Inhibitor Teva Canada Limited. 30 Novopharm Court Toronto, Ontario M1B 2K9 Date of Revision: February 3, 2016 Submission Control No: 191289 _ _ _TEVA-DONEPEZIL _ _Page 2 of 51_ Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 3 SUMMARY PRODUCT INFORMATION ....................................................................... 3 INDICATIONS AND CLINICAL USE ............................................................................. 3 CONTRAINDICATIONS .................................................................................................. 3 WARNINGS AND PRECAUTIONS ................................................................................. 3 ADVERSE REACTIONS ................................................................................................... 8 DRUG INTERACTIONS ................................................................................................. 16 DOSAGE AND ADMINISTRATION ............................................................................. 18 OVERDOSAGE ............................................................................................................... 19 ACTION AND CLINICAL PHARMACOLOGY ........................................................... 19 STORAGE AND STABILITY ......................................................................................... 22 DOSAGE FORMS, COMPOSITION AND PACKAGING ............................................ 22 PART II: SCIENTIFIC INFORMATION ............................................................................... 23 PHARMACEUTICAL INFORMATION ......................................................................... 23 DETAILED PHARMACOLOGY .................................................................................... 33 TOXICOLOGY ......................................................................................................... Կարդացեք ամբողջական փաստաթուղթը